MicroRNA-29a-3p Attenuates ET-1-induced Hypertrophic Responses in H9c2 Cardiomyocytes

Man Li,Nan Wang,Jian Zhang,Hong-Peng He,Hui-Qin Gong,Rui Zhang,Tie-Feng Song,Li -Nan Zhang,Zhi-Xia Guo,Dong-Sun Cao,Tong-Cun Zhang
DOI: https://doi.org/10.1016/j.gene.2016.03.015
IF: 3.913
2016-01-01
Gene
Abstract:Transcription factor nuclear factor of activated T cells c4 (NFATc4) is the best-characterized target for the development of cardiac hypertrophy. Aberrant microRNA-29 (miR-29) expression is involved in the development of cardiac fibrosis and congestive heart failure. However, whether miR-29 regulates hypertrophic processes is still not clear. In this study, we investigated the potential functions of miR-29a-3p in endothelin-1 (ET-1)-induced cardiomyocyte hypertrophy. We showed that miR-29a-3p was down-regulated in ET-1-treated H9c2 cardiomyocytes. Overexpression of miR-29a-3p significantly reduced ET-1-induced hypertrophic responses in H9c2 cardiomyocytes, which was accompanied by a decrease in NFATc4 expression. miR-29a-3p targeted directly to the 3′-UTR of NFATc4 mRNA and silenced NFATc4 expression. Our results indicate that miR-29a-3p inhibits ET-1-induced cardiomyocyte hypertrophy via inhibiting NFATc4 expression.
What problem does this paper attempt to address?